Ocuphire Pharma is a late clinical-stage ophthalmic biopharmaceutical company based in Rockville, MD, specializing in the development and commercialization of therapies for retinal and refractive eye disorders.
The company's product pipeline includes APX3330, an oral tablet targeting diabetic retinopathy and diabetic macular edema, and Phentolamine Ophthalmic Solution 0.75, an eye drop formulation designed to address pharmacologically-induced mydriasis, presbyopia, and dim light or night vision disturbances.
Generated from the website